The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y
In the context of radiopharmacy and molecular imaging, the concept of theranostics entails a therapy-accompanying diagnosis with the aim of a patient-specific treatment. Using the adequate diagnostic radiopharmaceutical, the disease and the state of the disease are verified for an individual patient...
Main Authors: | Frank Rösch, Hans Herzog, Syed M. Qaim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/10/2/56 |
Similar Items
-
Up-to-Date Optimization of the 90Y-PET/CT Reconstruction Protocol for Volumetric Quantification in Trans-Arterial RadioEmbolization (TARE) Procedures in the Era of Theranostics
by: Amedeo Capotosti, et al.
Published: (2022-08-01) -
Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres
by: Karin Knešaurek, et al.
Published: (2018-08-01) -
Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
by: Justin K. Mikell, et al.
Published: (2018-11-01) -
Y-90 SIRT: evaluation of TCP variation across dosimetric models
by: Benjamin J. Van, et al.
Published: (2021-06-01) -
Calculation of absorbed dose due to the 90Y-DOTATOC peptide receptor radionuclide therapy by MCNP5/X
by: Jeremić Marija Ž., et al.
Published: (2018-01-01)